Association of Lymphopenia Severity with Clinical Outcomes in Patients with COVID-19
Subject Areas :
MOEIN SOBHANI
1
,
Sharareh Kharazmi
2
*
1 - Faculty of Medicine, Ke.C., Islamic Azad University, Kerman, Iran
2 - Faculty of Medicine, Ke.C., Islamic Azad University, Kerman, Iran
Keywords: COVID-19, Lymphopenia, HRCT, Oxygen saturation, ICU, absolute lymphocyte count,
Abstract :
Lymphopenia is a decrease in the number of circulating lymphocytes. Often, the number of lymphocytes decreases in patients with Covid-19. This study aimed to investigate the association between lymphopenia severity and clinical outcomes in patients with COVID-19. A total of 196 COVID-19 patients with a mean age of 53.18 years were included in this cross-sectional study. Patients were over 18 years of age with a positive PCR test or arterial blood oxygen less than 92% requiring oxygen who referred to the emergency department of Payambar-e-Azam Kerman Hospital in 2021. Then the patients were classified and matched into 4 groups based on the number of lymphocytes. Demographic variables, clinical information related to lymphocyte count, length of hospitalization, disease severity, need for ventilation, patient outcome, and arterial blood oxygen saturation were recorded using patient records. Patients with mild lymphopenia had a higher average age (57.33 years) than the other groups. Patients with severe lymphopenia were mostly in the acute respiratory phase (42.9%). A total of one person among the examined people was admitted to the ICU, who was placed in the severe category in terms of lymphopenia. 173 of the examined people needed ventilation. Interestingly, patients with severe lymphopenia had a lesser mean arterial blood oxygen saturation (90.71) than the other groups. Patients with severe lymphopenia had a higher average length of hospitalization than the other groups and had a higher average high-resolution computed tomography (HRCT) than the other groups. The severity of lymphopenia was not significant according to gender, but it was significant according to age, disease severity, disease severity, ICU hospitalization, disease outcome, arterial blood oxygen, length of hospitalization, and HRCT. These results suggest that lymphopenia and its severity may serve as reliable predictors for clinical outcomes in managing COVID-19 patients.
1. Wondmeneh, T.G. and J.A. Mohammed, COVID-19 mortality rate and its. 2024.
2. COVID-19 epidemiological update – 15 March 2024. 2024; Available from: https://www.who.int/publications/m/item/covid-19-epidemiological-update-15-march-2024.
3. Zhou, P., et al., A pneumonia outbreak associated with a new coronavirus of probable bat origin. nature, 2020. 579(7798): p. 270-273.
4. Wu, F., et al., A new coronavirus associated with human respiratory disease in China. Nature, 2020. 579(7798): p. 265-269.
5. Khamis, A.H., et al., Clinical and laboratory findings of COVID-19: A systematic review and meta-analysis. Journal of the Formosan Medical Association, 2021. 120(9): p. 1706-1718.
6. Xavier, A.R., et al., COVID-19: clinical and laboratory manifestations in novel coronavirus infection. Jornal Brasileiro de Patologia e Medicina Laboratorial, 2020. 56: p. e3232020.
7. Alshipli, M., et al., Diagnostic role of laboratory findings and clinical symptoms in detecting the severity of COVID-19 disease. European Review for Medical & Pharmacological Sciences, 2023. 27(12).
8. Vetter, P., et al., Clinical features of covid-19. 2020, British Medical Journal Publishing Group.
9. Fathi, N. and N. Rezaei, Lymphopenia in COVID‐19: Therapeutic opportunities. Cell biology international, 2020. 44(9): p. 1792-1797.
10. Huang, I. and R. Pranata, Lymphopenia in severe coronavirus disease-2019 (COVID-19): systematic review and meta-analysis. Journal of intensive care, 2020. 8: p. 1-10.
11. Lee, J., et al., Lymphopenia as a biological predictor of outcomes in COVID-19 patients: a nationwide cohort study. Cancers, 2021. 13(3): p. 471.
12. Wagner, J., et al., Absolute lymphocyte count is a prognostic marker in Covid‐19: a retrospective cohort review. International journal of laboratory hematology, 2020. 42(6): p. 761-765.
13. Tan, L., et al., Lymphopenia predicts disease severity of COVID-19: a descriptive and predictive study. Signal transduction and targeted therapy, 2020. 5(1): p. 33.
14. Mulchandani, R., T. Lyngdoh, and A.K. Kakkar, Deciphering the COVID‐19 cytokine storm: systematic review and meta‐analysis. European journal of clinical investigation, 2021. 51(1): p. e13429.
15. Liao, Y.-C., et al., IL-19 induces production of IL-6 and TNF-α and results in cell apoptosis through TNF-α. The Journal of Immunology, 2002. 169(8): p. 4288-4297.
16. Fischer, K., et al., Inhibitory effect of tumor cell-derived lactic acid on human T cells. Blood. 2007.
17. Martínez-Urbistondo, M., et al., Severe lymphopenia as a predictor of COVID-19 mortality in immunosuppressed patients. Journal of Clinical Medicine, 2021. 10(16): p. 3595.
18. Ripa, M., et al., Secondary infections in patients hospitalized with COVID-19: incidence and predictive factors. Clinical Microbiology and Infection, 2021. 27(3): p. 451-457.
19. Zhao, W., et al., Clinical characteristics and durations of hospitalized patients with COVID-19 in Beijing: a retrospective cohort study. MedRxiv, 2020: p. 2020.03. 13.20035436.
20. Manal, M., et al., Lymphopenia in Covid-19: a single center retrospective study of 589 cases. Annals of medicine and surgery, 2021. 69.
21. Tareq, A.A., N.M. Hameed, and T.S. Abdulshaheed, Impact of lymphopenia on COVID-19 infection severity. Medical Journal of Babylon, 2022. 19(1): p. 99-101.
22. Huang, C., et al., Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. The lancet, 2020. 395(10223): p. 497-506.
23. Chen, R., et al., Longitudinal hematologic and immunologic variations associated with the progression of COVID-19 patients in China. Journal of Allergy and Clinical Immunology, 2020. 146(1): p. 89-100.
24. Yuan, X., et al., Changes of hematological and immunological parameters in COVID-19 patients. International journal of hematology, 2020. 112: p. 553-559.
25. Liao, D., et al., Haematological characteristics and risk factors in the classification and prognosis evaluation of COVID-19: a retrospective cohort study. The Lancet Haematology, 2020. 7(9): p. e671-e678.
26. Fan, B.E., et al., Hematologic parameters in patients with COVID-19 infection. American journal of hematology, 2020. 95(6): p. E131-E134.
27. Chu, H., et al., Middle East respiratory syndrome coronavirus efficiently infects human primary T lymphocytes and activates the extrinsic and intrinsic apoptosis pathways. The Journal of infectious diseases, 2016. 213(6): p. 904-914.